1. 1. p53 as a unique target of action of cisplatin in acute leukemia cells. Journal of Cellular and Molecular Medicine (Accepted on 26th June, 2022).
2. Sanjay kumar, Paul B. Tchounwou. Arsenic trioxide reduces the expression of E2F1, cyclin E, and phosphorylation of PI3K signaling molecules in acute leukemia cells. Environmental Toxicology 36 (2021), issue 9, 1785-1792.
3. Paul B. Tchounwou, Shaloam Dasari, Felicite Noubissi, Paresh Ray, Sanjay Kumar. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy. J. Experimental Pharmacol. 13 (2021), 303-328.
4. Sanjay kumar, Paul B. Tchounwou.Trisenox disrupts MDM2-DAXX-HAUSP complex and induces apoptosis in a mice model of acute promyelocyte leukemia. J. Cancer, 11 (2020):4373-4383. doi:10.7150/jca.39996.
5. Andrea Brown, Sanjay Kumar, Paul B Tchounwou. Cisplatin-Based Chemotherapy of Human Cancers. J CancerSci Ther11(2019):097-103.
6. Paul B. Tchounwou, Clement G. Yedjou, Udensi K. Udensi, Maricica Pacurari, Jacqueline J. Stevens, Anita K.Patlolla, Felicite Noubissi, and Sanjay Kumar. State of the science review of the health effects of inorganic arsenic: perspectives for future research. Environmental Toxicology 34 (2019): 188-202
7. Sanjay kumar, Andrea Brown, Paul B. Tchounwou. Trisenox disrupts MDM2-DAXX-HAUSP complex and activates p53, cell cycle regulation and apoptosis in acute leukemia cells. Oncotarget 9 (2018): 33138-33148.
8. Sanjay kumar, Ibrahim O. Farah, Paul B. Tchounwou. Trisenox induces cytotoxicity through phosphorylation of mitogen‐activated protein kinase molecules in acute leukemia cells. J Biochem Mol Toxicol. 2018 Aug 8:e22207. https://doi.org/10.1002/jbt.22207 ( https://www.ncbi.nlm.nih.gov/pubmed/30091188). doi: 10.1002/jbt.22207.
9. Sanjay kumar, Paul B. Tchounwou. Molecular mechanism of cisplatin cytotoxicity in acute leukemia cells. Oncotarget 6 (2015): 40734-40746.
10. Sanjay kumar, Clement J. Yedju and Paul B. Tchounwou. Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. J Exp Clin Cancer Res. 33(2014): 42.
11. Venkatesh Kundumani-Sridharan, Nikhlesh K. Singh, Sanjay Kumar and Gadiparthi N.Rao., Nuclear factor of activated T cells c1 mediates p21-activated kinase 1 activation in the modulation of chemokine-induced human aortic smooth muscle cell F-actin stress fiber formation, migration and proliferation and injury-induced vascular wall remodeling. J. Biol. Chem. 288(2013): 22150-22162.
12. Nikhlesh K. Singh, Venkatesh Kundumani-Sridharan, Sanjay Kumar, Shailendra K. Verma, Sivareddy Kotla, Hideyuki Mukai, Heckle M.R and Gadiparthi N.Rao.PKN1 is a novel substrate for NFATc1-mediated cyclin D1-CDK6 activity and modulates vascular smooth muscle cell division and migration leading to inward blood vessel wall remodeling. J. Biol. Chem. 287(2012):36291-36304.
13. Sanjay Kumar, Saikat Chakraverty, Cindy Balbosa, Tatiana Brustovetsky, Nickolay
Brustovetsky and Alexander G. Obukhov. Mechanisms controlling neurite outgrowth in Rat pheochromocytoma cell line: The role of TRPC channels. J. Cell. Physiol. 227 (2012):1408-1419.
14. Saikat Chakraverty, Zachary C.Berwick, Paula J.Bartlett, Sanjay Kumar, Andrew P. Thomas, Michael Sturek, Jonathan D. Tune, and Alexander G. Obukhov. Bromoenol Lactone (BEL) inhibits Cav1.2, and TRPC channels. J. Pharmacol. Exp. Ther.339 (2011):329-340.
15. Zachary P. Neeb, Jason M. Edwards, Mouhamad A. Alloosh, Xin Long, Ian N. Bratz,Cassandra R. Peller, James P. Byrd, Sanjay Kumar, Alexander G. Obukhov, Michael Sturek. Exercise training decreases store-operated Ca2+ entry associated with metabolic syndrome and coronary atherosclerosis. Cardiovasc. Res. 85(2010) 631-640.
16. Guoqing Hu, Elena A. Oboukhova, Sanjay Kumar, Michael Sturek, Alexander G. Obukhov. Canonical Transient Receptor Potential Channels Expression is Elevated in a Porcine Model of Metabolic Syndrome. Mol. Endocrinol. 23(2009), 689-699.
17. Sanjay Kumar, Mithu Guha, Vinay Choubey, Pallab Maity, Kumkum Srivastava, Sunil K Puri and Uday Bandyopadhyay. Bilirubin inhibits Plasmodium falciparum growth through the generation of reactive oxygen species. Free Rad. Biol. Med. 44 (2008), 602-613.
18. Sanjay Kumar, Sajal Kumar Das, Sumanta Dey, Pallab Maity, Mithu Guha, Vinay Choubey, Gautam Panda and Uday Bandyopadhyay. Antiplasmodial Activity of [(Aryl) arylsulfanylmethyl]pyridine.Antimicrob. Agents Chemother. 52 (2008), 705-715.
19. Sanjay Kumar, Mithu Guha, Vinay Choubey, Pallab Maity, Uday Bandyopadhyay “Antimalarial drugs inhibiting hemozoin (β hematin) formation: A mechanistic update. Life Sci. 80 (2007), 813-828.
20. Sanjay Kumar, Uday Bandyopadhyay “Free heme toxicity and its detoxification systems in human. Toxicol.Letts. 157 (2005), 175-188.
21. Mithu Guha, Sanjay Kumar,Vinay Choubey, Pallab Maity, Uday Bandyopadhyay. “
Apoptosis in the liver during malaria: Role of oxidative stress and implication of the mitochondrial pathway.” FASEB J. 20 (2006), E439-E449.
22. Vinay Choubey, Mithu Guha, Pallab Maity, Sanjay Kumar, Resmi Raghunandan, Prakas R. Maulik, Umesh C. Halder, Uday Bandyopadhyay “Molecular characterization and localization of Plasmodium falciparum choline kinase.” Biochim Biophys Acta. 1760 (2006), 1027-1038.
23. Mithu Guha, Vinay Choubey, Pallab Maity, Sanjay Kumar, Kumkum Shrivastava, Sunil K. Puri and Uday Bandyopadhyay. Overexpression, purification and localization of apoptosis related protein from Plasmodium falciparum. Protein Expr.Purif. 52 (2007), 363-372.
24. Vinay Choubey, Pallab Maity, Mithu Guha, Sanjay Kumar, Kumkum Shrivastava, Sunil Kumar Puri and Uday Bandyopadhyay. Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: A possible antimalarial mechanism of hexadecyltrimethylammonium bromide. Antimicrob. Agents Chemother. 51 (2007), 696-706.